Biora Therapeutics, Inc.
BIOR · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $18 | $225,037 | $215 | $335 |
| - Cash | $3 | $5 | $11 | $15 |
| + Debt | $40 | $47 | $47 | $47 |
| Enterprise Value | $55 | $225,079 | $251 | $367 |
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | -89.9% | -41.3% | -37.8% | – |
| Gross Profit | $0 | $0 | $1 | -$0 |
| % Margin | 100% | 65.4% | 100% | -13.4% |
| EBITDA | -$16 | $7 | -$1 | -$14 |
| % Margin | -50,709.4% | 2,270.1% | -236% | -1,579.1% |
| Net Income | -$18 | $6 | -$4 | -$15 |
| % Margin | -57,506.3% | 2,033% | -772.9% | -1,767.5% |
| EPS Diluted | -5.04 | 0 | -0.14 | -0.62 |
| % Growth | – | 100% | 77.4% | – |
| Operating Cash Flow | $32 | -$11 | -$12 | -$14 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $32 | -$11 | -$13 | -$14 |